Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |